I think that this shows the urgency that the FDA attach to Bronchitol reaching patients.
Seems a fair call, judging by Bronchitol sales everywhere else in the world.
Still, I'm fairly sure that PXS will end up with their payment from Chiesi. The best that Chiesi can hope for is a Christmas card from PXS.
Ann: Bronchitol NDA Resubmission - FDA Decision Date 1 November, page-5
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.76M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 99162 | 1 |
View Market Depth
| Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
| SNT (ASX) Chart |
Day chart unavailable